Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).
about
Ubiquitination in melanoma pathogenesis and treatment.Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.Systemic inhibition of neddylation by 3-day MLN4924 treatment regime does not impair autophagic flux in mouse hearts and brains.Ceritinib Enhances the Efficacy of Trametinib in BRAF/NRAS-Wild-Type Melanoma Cell Lines.
P2860
Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting the protein ubiquiti ...... ibitor pevonedistat (MLN4924).
@en
type
label
Targeting the protein ubiquiti ...... ibitor pevonedistat (MLN4924).
@en
prefLabel
Targeting the protein ubiquiti ...... ibitor pevonedistat (MLN4924).
@en
P2093
P2860
P1476
Targeting the protein ubiquiti ...... ibitor pevonedistat (MLN4924).
@en
P2093
Alice McDonald
Allison Berger
Anna Spreafico
Heather M Selby
John J Tentler
Lindsey N Micel
Peter F Smith
Peter J Klauck
S Gail Eckhardt
Stacey M Bagby
P2860
P2888
P356
10.1007/S10637-016-0398-8
P577
2016-10-25T00:00:00Z
P6179
1052320211